蘇彥豪(Su, Yen-Hao) 助理教授

Email
su11066@tmu.edu.tw
現   職
外科學科 助理教授

學經歷

學 歷

畢業學校與學位[修業時間]
臺灣大學醫學系 學士
1996/09~2003/06

本校學術經歷

任職單位與職稱[起迄時間]
外科學科助理教授
2021/08/01~
外科學科講師
2017/02/24~2021/07/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
無資料!

其它經歷

任職單位與職稱[起迄時間]
雙和醫院一般外科主治醫師
桃園敏盛醫院外科部主治醫師
2008/07~2011/03

專長與研究領域

學門領域
學術專長
醫學
Medical Science
一般外科
一般外科
內視鏡外科
內視鏡外科
外科重症醫學
外科重症醫學
外科腫瘤學
外科腫瘤學
外科營養
外科營養
肝膽胰外科
肝膽胰外科
急診外科
急診外科
消化系外科
消化系外科
移植醫學
移植醫學
創傷醫學
創傷醫學

論文著作

清冊下載


1. 2023 Meng-Chao Chen,YEN-HAO SU, Kuo-Hung Huang,Wen-Liang Fang. The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery . Journal of the Chinese Medical Association .2023

2. 2023 SU YT,SU YH,Shen SC. Prediction of 5-Year Weight Loss and Weight Regain According to Early Weight Loss after Sleeve Gastrectomy . Obesity Surgery .2023

3. 2023 Su CM,Chen SA,Huang MT,Liao PH. Chaperone-mediated autophagy degrade Dicer to promote breast cancer metastasis . Journal of Cellular Physiology .2023

4. 2023 Tung-Wei Hsu,Yen-Hao Su,Hsin-An Chen,Po-Hsiang Liao ,Shih-Chiang shen. Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis . Aging .2023 ;(15):6503-6525

5. 2023 Yu-Wen Yeh,Tung-Wei Hsu,Yen-Hao Su. Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression . Aging .2023 ;(15):12873-12889

6. 2022 Chiu CF,SU YH, Chang CF. Organic cation transporter 2 activation enhances sensitivity to oxaliplatin in human pancreatic ductal adenocarcinoma . Biomed Pharmacother . .2022

7. 2022 Park JM,SU YH,Chiu CF,Shen YS. Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer . Molecular Metabolism .2022

8. 2022 Park JM,SU YH,Chen HA,Chiu CF. A case-control study in Taiwanese cohort and meta-analysis of serum ferritin in pancreatic cancer . Scientific Reports .2022

9. 2022 Yu-Ming Wu,YEN-HAO SU ,Ying-Hsuan Tai . A Comparison of Oxygenation Efficacy between High-Flow Nasal Cannulas and Standard Facemasks during Elective Tracheal Intubation for Patients with Obesity: A Randomized Controlled Trial . Journal of Clinical Medicine .2022 ;(11(6))

10. 2022 Yu-Ming Wu,YEN-HAO SU,Ying-Hsuan Tai . Morphometric and ultrasonographic determinants of difficult laryngoscopy in obese patients: A prospective observational study . Journal of the Chinese Medical Association .2022

11. 2022 Tung-Wei Hsu,Hsin-An Chen,Po-Hsiang Liao,Yen-Hao Su,Chin-Ming Su. Dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells . Aging .2022

12. 2021 Efficacy of Different Procedures of Metabolic Surgery for Type 2 Diabetes in Asia: a Multinational and Multicenter Exploratory Study. . Obesity Surgery .2021

13. 2021 Chih-Ming Su,YEN-HAO SU,Hsin-An Chen,Po-Hsiang Liao . AXL is crucial for E1A-enhanced therapeutic efficiency of EGFR tyrosine kinase inhibitors through NFI in breast cancer . Environ Toxicol .2021 ;(36(7)):1278-1287

14. 2021 Po-Jen Yang,Yen-Hao Su, Shih-Chiang Shen, Po-Chu Lee,Wei-Jei Lee ,Weu Wang. Predictors of diabetes relapse after metabolic surgery in Asia . Surg Obes Relat Dis .2021

15. 2021 Hsin-An Chen,YEN-HAO SU. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells . Aging .2021 ;(13(8)):12046-12057

16. 2021 Yu-Ming Wu,YEN-HAO SU,Ying-Hsuan Tai . Recovery Profiles of Sevoflurane and Desflurane with or without M-Entropy Guidance in Obese Patients: A Randomized Controlled Trial . J Clin Med . .2021 ;(11(1)):162-162

17. 2020 Wu-Min Huang,Yen-Hao Su. Long-term outcomes of metabolic surgery in overweight and obese patients with type 2 diabetes in Asia . Diabetes Obes Metab .2020

18. 2020 Efficacy of Fibrin Sealant in Reducing Complication Risk After Bariatric Surgery: a Systematic Review and Meta-analysis. . Obesity Surgery .2020 ;(31(3)):1158-1167

19. 2020 SU YH,Chiu CF. ERK-mediated transcriptional activation of Dicer is involved in gemcitabine resistance of pancreatic cancer . Journal of Cellular Physiology .2020

20. 2019 Wu CT,SU YH. Gender difference of CCAAT/enhancer binding protein homologous protein deficiency in susceptibility to osteopenia . Journal of Orthopaedic Surgery and Research .2019 ;(37):942-947

21. 2019 Shen SC,Su YH. Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy . Obesity Surgery .2019 ;(29):221-229

22. 2016 Su YH,Lin CM. Folate deficient tumor microenvironment promotes epithelial-to-mesenchymal transition and cancer stem-like phenotypes. . Oncotarget .2016 ;(31):3324-3356

23. 2016 Shian-Ying Sung,Yen-Hao Su. Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth . PloS One .2016

24. 2016 SU CM,Wang MY,Hong CC,Chen HA,Su YH. miR-520h is crucial for DAPK2 regulation and breast cancer progression . Oncogene .2016 ;(35):1134-1142

25. 2015 Su YH,Tang WC. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer . Biochim Biophys Acta .2015 ;(1853):2261-2272

26. 2014 Su CM,Su YH. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma. . Ann Surg Oncol .2014 ;(21):S767-S775

27. 2014 Chen JC,Su YH. Suppression of Dicer Increases Sensitivity to Gefitinib in Human Lung Cancer Cells . Ann Surg Oncol. .2014 ;(21):S555-S563

28. 2014 Chang YW,Su CM,Su YH. Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects . Oncotarget .2014 ;(5):3823-3835

研究計畫

計畫名稱
108 探討脯氨酸循環調控癌細胞代謝重組與癌幹源性在胰臟癌中對gemcitabine抗藥性的影響
補助單位
科技部

計畫名稱
106 探討Dicer在胰臟癌細胞對gemcitabine感受性的影響及其調控機制(3/3)
補助單位
科技部

計畫名稱
105 探討Dicer在胰臟癌細胞對gemcitabine感受性的影響及其調控機制(2/3)
補助單位
科技部

計畫名稱
105 探討Dicer在胰臟癌細胞對gemcitabine感受性的影響及其調控機制(2/3)
補助單位

計畫名稱
104 探討Dicer在胰臟癌細胞對gemcitabine感受性的影響及其調控機制(1/3)
補助單位
科技部

計畫名稱
104 探討Dicer在胰臟癌細胞對gemcitabine感受性的影響及其調控機制(1/3)
補助單位
科技部